A detailed history of Ubs Asset Management Americas Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,483,247 shares of BDX stock, worth $335 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,483,247
Previous 1,606,889 7.69%
Holding current value
$335 Million
Previous $376 Million 4.78%
% of portfolio
0.09%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $27.4 Million - $30 Million
-123,642 Reduced 7.69%
1,483,247 $358 Million
Q2 2024

Aug 13, 2024

BUY
$225.07 - $246.17 $9.02 Million - $9.86 Million
40,066 Added 2.56%
1,606,889 $376 Million
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $1.16 Million - $1.23 Million
-4,959 Reduced 0.32%
1,566,823 $388 Million
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $12.5 Million - $14.4 Million
53,903 Added 3.55%
1,571,782 $383 Million
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $13.4 Million - $14.9 Million
52,415 Added 3.58%
1,517,879 $392 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $8.46 Million - $9.55 Million
36,831 Added 2.58%
1,465,464 $363 Million
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $1.89 Million - $2.22 Million
8,648 Added 0.61%
1,428,633 $363 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $1.32 Million - $6.85 Million
25,925 Added 1.86%
1,419,985 $316 Million
Q2 2022

Aug 12, 2022

SELL
$234.74 - $275.42 $16 Million - $18.8 Million
-68,170 Reduced 4.66%
1,394,060 $344 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $896,595 - $995,366
-3,680 Reduced 0.25%
1,462,230 $379 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $16.8 Million - $18.3 Million
72,947 Added 5.24%
1,465,910 $360 Million
Q3 2021

Nov 15, 2021

BUY
$232.72 - $256.47 $5.48 Million - $6.04 Million
23,559 Added 1.72%
1,392,963 $334 Million
Q2 2021

Aug 16, 2021

SELL
$232.65 - $254.58 $6.96 Million - $7.61 Million
-29,908 Reduced 2.14%
1,369,404 $325 Million
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $11.9 Million - $13.1 Million
51,089 Added 3.79%
1,399,312 $332 Million
Q4 2020

Mar 01, 2021

BUY
$221.92 - $245.94 $35.2 Million - $39 Million
158,600 Added 13.33%
1,348,223 $329 Million
Q3 2020

Nov 13, 2020

BUY
$215.77 - $276.76 $22.8 Million - $29.2 Million
105,449 Added 9.73%
1,189,623 $270 Million
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $6.77 Million - $8.11 Million
-30,801 Reduced 2.76%
1,084,174 $253 Million
Q1 2020

May 15, 2020

BUY
$195.69 - $279.01 $20.5 Million - $29.2 Million
104,602 Added 10.35%
1,114,975 $250 Million
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $9.3 Million - $10.5 Million
39,326 Added 4.05%
1,010,373 $268 Million
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $1.34 Million - $1.48 Million
-5,796 Reduced 0.59%
971,047 $240 Million
Q2 2019

Aug 15, 2019

BUY
$217.4 - $246.08 $2.36 Million - $2.67 Million
10,855 Added 1.12%
976,843 $0
Q1 2019

May 14, 2019

BUY
$206.05 - $248.17 $1.17 Million - $1.41 Million
5,693 Added 0.59%
965,988 $0
Q4 2018

Feb 13, 2019

BUY
$204.73 - $257.93 $9.41 Million - $11.9 Million
45,943 Added 5.02%
960,295 $211 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $1.17 Million - $1.29 Million
5,035 Added 0.55%
914,352 $0
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $19.5 Million - $21.9 Million
-93,796 Reduced 9.35%
909,317 $0
Q1 2018

May 14, 2018

BUY
$205.46 - $240.27 $14.4 Million - $16.8 Million
70,027 Added 7.5%
1,003,113 $0
Q4 2017

Feb 09, 2018

BUY
$189.0 - $222.64 $24.9 Million - $29.3 Million
131,617 Added 16.42%
933,086 $0
Q3 2017

Nov 13, 2017

BUY
$186.89 - $198.9 $150 Million - $159 Million
801,469
801,469 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.